Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Other Operating Expenses (2017 - 2024)

iBio (IBIO) has disclosed Other Operating Expenses for 10 consecutive years, with $1.0 million as the latest value for Q1 2024.

  • On a quarterly basis, Other Operating Expenses changed N/A to $1.0 million in Q1 2024 year-over-year; TTM through Dec 2024 was $1.0 million, a N/A change, with the full-year FY2024 number at $1.0 million, changed N/A from a year prior.
  • Other Operating Expenses was $1.0 million for Q1 2024 at iBio, down from $5.7 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.7 million in Q4 2022 to a low of -$3.2 million in Q1 2022.
  • A 4-year average of $640583.3 and a median of -$134500.0 in 2020 define the central range for Other Operating Expenses.
  • Biggest YoY gain for Other Operating Expenses was 9385.25% in 2022; the steepest drop was 517.43% in 2022.
  • iBio's Other Operating Expenses stood at -$247000.0 in 2020, then soared by 75.3% to -$61000.0 in 2021, then skyrocketed by 9385.25% to $5.7 million in 2022, then plummeted by 82.34% to $1.0 million in 2024.
  • Per Business Quant, the three most recent readings for IBIO's Other Operating Expenses are $1.0 million (Q1 2024), $5.7 million (Q4 2022), and $5.1 million (Q2 2022).